Enzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a research report report published on Saturday. The brokerage issued a hold rating on the medical research company’s stock.

Enzo Biochem Price Performance

Shares of NYSE:ENZ opened at $0.47 on Friday. Enzo Biochem has a 52 week low of $0.41 and a 52 week high of $1.30. The company’s 50 day moving average is $0.57 and its two-hundred day moving average is $0.87.

Enzo Biochem (NYSE:ENZ) last posted its earnings results on Monday, March 17th. The medical research company reported ($0.02) EPS for the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Mink Brook Asset Management LLC purchased a new stake in Enzo Biochem in the fourth quarter valued at $577,000. Lepercq Multi Asset Fund acquired a new stake in shares of Enzo Biochem during the fourth quarter worth about $88,000. BBR Partners LLC purchased a new stake in shares of Enzo Biochem in the 3rd quarter valued at about $112,000. Wittenberg Investment Management Inc. boosted its position in shares of Enzo Biochem by 60.1% in the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after purchasing an additional 70,400 shares during the period. Finally, Virtu Financial LLC purchased a new position in Enzo Biochem during the 4th quarter worth approximately $35,000. Institutional investors and hedge funds own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.